- Home
- ADTX vs NDRA Comparison
ADTX vs NDRA Comparison
Compare ADTX & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- NDRA
- Stock Information
- Founded
- ADTX 2017
- NDRA 2007
- Country
- ADTX United States
- NDRA United States
- Employees
- ADTX N/A
- NDRA N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ADTX Health Care
- NDRA Health Care
- Exchange
- ADTX Nasdaq
- NDRA Nasdaq
- Market Cap
- ADTX 5.1M
- NDRA 3.1M
- IPO Year
- ADTX 2020
- NDRA 2017
- Fundamental
- Price
- ADTX $1.04
- NDRA $4.28
- Analyst Decision
- ADTX
- NDRA Strong Buy
- Analyst Count
- ADTX 0
- NDRA 1
- Target Price
- ADTX N/A
- NDRA $46.00
- AVG Volume (30 Days)
- ADTX 316.0K
- NDRA 62.3K
- Earning Date
- ADTX 08-14-2025
- NDRA 08-14-2025
- Dividend Yield
- ADTX N/A
- NDRA N/A
- EPS Growth
- ADTX N/A
- NDRA N/A
- EPS
- ADTX N/A
- NDRA N/A
- Revenue
- ADTX $12,051.00
- NDRA N/A
- Revenue This Year
- ADTX $15,768.94
- NDRA N/A
- Revenue Next Year
- ADTX N/A
- NDRA N/A
- P/E Ratio
- ADTX N/A
- NDRA N/A
- Revenue Growth
- ADTX N/A
- NDRA N/A
- 52 Week Low
- ADTX $0.81
- NDRA $2.90
- 52 Week High
- ADTX $6,500.00
- NDRA $22.68
- Technical
- Relative Strength Index (RSI)
- ADTX 43.98
- NDRA 41.72
- Support Level
- ADTX $1.01
- NDRA $4.42
- Resistance Level
- ADTX $1.13
- NDRA $4.35
- Average True Range (ATR)
- ADTX 0.07
- NDRA 0.32
- MACD
- ADTX 0.01
- NDRA -0.01
- Stochastic Oscillator
- ADTX 30.00
- NDRA 30.43
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.